British American Tobacco plc offers tobacco and nicotine products to consumers around the world. The company is headquartered in London, the United Kingdom.
| Revenue (TTM) | $25.78B |
| Gross Profit (TTM) | $21.32B |
| EBITDA | $11.20B |
| Operating Margin | 34.90% |
| Return on Equity | 13.40% |
| Return on Assets | 5.12% |
| Revenue/Share (TTM) | $2.37 |
| Book Value | $5.68 |
| Price-to-Book | 1.86 |
| Price-to-Sales (TTM) | 4.64 |
| EV/Revenue | 4.767 |
| EV/EBITDA | 10.12 |
| Quarterly Earnings Growth (YoY) | -28.60% |
| Quarterly Revenue Growth (YoY) | 1.40% |
| Shares Outstanding | $2.15B |
| Float | $9.86B |
| % Insiders | 0.10% |
| % Institutions | 15.69% |
Volatility is currently expanding
British American Tobacco PLC (LSE:BATS) could deliver years of accelerating growth as its investment in smokeless products starts to pay off, according to Jefferies. The broker, which rates the shares "buy" with a 5,500p target, said the company is at a turning point, with next-generation products set to drive around half of group revenue growth in the medium term.
Tobacco companies spend almost nothing on new equipment yet generate billions in cash, and a handful of US-listed names funnel that surplus straight into shareholder pockets through yields that most sectors cannot touch.
Altria and British American Tobacco both flood retirement accounts with cash, but the tobacco giant pulling ahead on growth, valuation, and smokeless momentum is not the one with 60 consecutive dividend raises.
Philip Morris, British American Tobacco and Altria have been highlighted in this Industry Outlook article.
PM, BTI and MO are navigating volume pressure and rising costs by expanding smoke-free portfolios and adapting to shifting consumer demand.
British American Tobacco's Modern Oral segment grew 65.9% in H1'26 and is now the company's largest New Category while holding a 39.2% volume share in top markets. Sweden, Norway, Poland, and the US show how oral nicotine expands the pool of users as cigarettes decline. A reverse DCF shows that the shares at $55 look to price Modern Oral at a mere 16% CAGR, while this segment has been compounding at 47-66% recently.
British American Tobacco offers compelling value trading at 11.5x forward earnings with a 6% dividend yield. NGP revenue grew 18% YoY, with Velo now the global leader in Modern Oral and strong U.S. market share gains. Management guides for 5–8% adjusted EPS growth in 2026, supported by NGP momentum and improving profitability.
Federal Hemp Framework and Healthcare Strategy Advance; Debenture Conversion Eliminates Largest Liability, Restores Positive Shareholders' Equity; Gross Margin Expands to 47.5% and Second Quarter Operating Cash Use Reduced to $0.9M Louisville, Colorado--(Newsfile Corp. - August 13, 2026) - Charlotte's Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF) ("Charlotte's Web" or the "Company"), a botanical wellness innovation company and the market leader in cannabidiol (CBD) hemp extract wellness products, today announced results for the quarter ended June 30, 2026. All amounts are expressed in U.S. dollars unless otherwise indicated.
At the 24% federal bracket, a $50,000 stream of ordinary dividend income hands roughly $12,000 to the IRS every year.
BANGALORE, India & LONDON--(BUSINESS WIRE)---- $ITC #AI--ITC Infotech today announced a landmark multi-year strategic technology deal with British American Tobacco (BAT).
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on BTI and any ticker you trade — then tracks every position and per-strategy win rate.
